19-18832393-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002911.4(UPF1):​c.184C>G​(p.Pro62Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000011 in 910,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000011 ( 0 hom. )

Consequence

UPF1
NM_002911.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.26

Publications

0 publications found
Variant links:
Genes affected
UPF1 (HGNC:9962): (UPF1 RNA helicase and ATPase) This gene encodes a protein that is part of a post-splicing multiprotein complex involved in both mRNA nuclear export and mRNA surveillance. mRNA surveillance detects exported mRNAs with truncated open reading frames and initiates nonsense-mediated mRNA decay (NMD). When translation ends upstream from the last exon-exon junction, this triggers NMD to degrade mRNAs containing premature stop codons. This protein is located only in the cytoplasm. When translation ends, it interacts with the protein that is a functional homolog of yeast Upf2p to trigger mRNA decapping. Use of multiple polyadenylation sites has been noted for this gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
UPF1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22346073).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UPF1NM_002911.4 linkc.184C>G p.Pro62Ala missense_variant Exon 1 of 24 ENST00000262803.10 NP_002902.2 Q92900-2A0A024R7L5
UPF1NM_001297549.2 linkc.184C>G p.Pro62Ala missense_variant Exon 1 of 24 NP_001284478.1 Q92900-1A0A024R7L8B3KY55
UPF1XM_017027105.3 linkc.184C>G p.Pro62Ala missense_variant Exon 1 of 24 XP_016882594.1
UPF1XM_017027106.3 linkc.184C>G p.Pro62Ala missense_variant Exon 1 of 24 XP_016882595.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UPF1ENST00000262803.10 linkc.184C>G p.Pro62Ala missense_variant Exon 1 of 24 1 NM_002911.4 ENSP00000262803.5 Q92900-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000110
AC:
1
AN:
910038
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
426158
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17398
American (AMR)
AF:
0.00
AC:
0
AN:
2910
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7394
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9792
South Asian (SAS)
AF:
0.00
AC:
0
AN:
17990
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10694
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2002
European-Non Finnish (NFE)
AF:
0.00000123
AC:
1
AN:
810184
Other (OTH)
AF:
0.00
AC:
0
AN:
31674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 12, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.184C>G (p.P62A) alteration is located in exon 1 (coding exon 1) of the UPF1 gene. This alteration results from a C to G substitution at nucleotide position 184, causing the proline (P) at amino acid position 62 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Uncertain
0.064
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
17
DANN
Benign
0.76
DEOGEN2
Benign
0.083
.;T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.68
T;T
M_CAP
Pathogenic
0.99
D
MetaRNN
Benign
0.22
T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
0.69
N;N
PhyloP100
2.3
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
0.050
N;.
REVEL
Benign
0.24
Sift
Benign
0.80
T;.
Sift4G
Benign
0.80
T;T
Polyphen
0.0050
B;B
Vest4
0.20
MutPred
0.20
Loss of glycosylation at P62 (P = 0.086);Loss of glycosylation at P62 (P = 0.086);
MVP
0.46
MPC
1.2
ClinPred
0.14
T
GERP RS
4.2
PromoterAI
-0.13
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.096
gMVP
0.15
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr19-18943202; API